機関投資家の保有一覧

Siren, L.L.C.

持ち方

—

評価額を取得中

届出上位5銘柄の比重

—

保有

115銘柄

Siren, L.L.C. は、2026年6月30日の SEC Form 13F で 115 銘柄の保有を報告しました。届出上位には Scholar Rock Holding、Kymera Therapeutics、Veradermics が並び、ヘルスケアにまたがります。下の銘柄名と保有株数は届出に基づきます。

届出上位の10銘柄

1
SR
SRRKScholar Rock Holding
ヘルスケア・ 9,575,013 株
—
2
KY
KYMRKymera Therapeutics
ヘルスケア・ 2,935,830 株
—
3
MA
MANEVeradermics
ヘルスケア・ 1,655,374 株
—
4
RV
RVMDRevolution Medicines
ヘルスケア・ 900,000 株
—
5
ER
ERASErasca
ヘルスケア・ 11,397,781 株
—
6
ON
ONCBeOne Medicines
ヘルスケア・ 465,000 株
—
7
TN
TNGXTango Therapeutics
ヘルスケア・ 6,179,364 株
—
8
EW
EWTXEdgewise Therapeutics
ヘルスケア・ 3,184,629 株
—
9
AR
ARWRArrowhead Pharmaceuticals
ヘルスケア・ 1,715,476 株
—
10
RY
RYTMRhythm Pharmaceuticals
ヘルスケア・ 1,136,275 株
—

残り 105 銘柄をすべて見る ▾

#	銘柄	保有株数	概算評価額
11	BCAXBicara Therapeutics	5,602,970	—
12	PBLSParabilis Medicines, Inc.	2,992,259	—
13	SYRESpyre Therapeutics	968,598	—
14	ELVNEnliven Therapeutics	1,774,411	—
15	LXRXLexicon Pharmaceuticals	44,303,518	—
16	SEPNSepterna	1,900,000	—
17	RLAYRelay Therapeutics	3,650,000	—
18	COAGHemab Therapeutics	2,086,834	—
19	RCUSArcus Biosciences	2,420,430	—
20	COGTCogent Biosciences	1,859,279	—
21	IRONDisc Medicine	888,401	—
22	GOSSGossamer Bio	5,208,968	—
23	ABVXAbivax	576,000	—
24	DFTXDefinium Therapeutics	1,419,493	—
25	SLDBSolid Biosciences	7,690,405	—
26	STOKStoke Therapeutics	1,995,347	—
27	XENEXenon Pharmaceuticals	1,318,564	—
28	CYTKCytokinetics	758,952	—
29	TSHATaysha Gene Therapies	9,846,579	—
30	AMLXAmylyx Pharmaceuticals	1,480,586	—
31	OLMAOlema Pharmaceuticals	4,856,949	—
32	ORICOric Pharmaceuticals	2,998,192	—
33	SLNSilence Therapeutics	3,311,438	—
34	PVLAPalvella Therapeutics	257,485	—
35	RELYRemitly Global	1,543,271	—
36	COFCapital One Financial	171,615	—
37	DYNDyne Therapeutics	2,129,125	—
38	GOOGLAlphabet	90,000	—
39	CGEMCullinan Therapeutics	1,893,410	—
40	DNLIDenali Therapeutics	1,396,513	—
41	ABSIAbsci	2,474,764	—
42	TBLATaboola.com	8,423,410	—
43	TRVITrevi Therapeutics	1,786,867	—
44	GPCRStructure Therapeutics	872,967	—
45	KLRAKailera Therapeutics	2,214,286	—
46	NVDANVIDIA	95,000	—
47	TSMTaiwan Semiconductor Manufacturing	44,700	—
48	ORKAOruka Therapeutics	250,000	—
49	MNPRMonopar Therapeutics	270,118	—
50	RAPPRapport Therapeutics	641,469	—
51	SPTXSeaport Therapeutics	1,095,316	—
52	DBVTDBV Technologies	1,857,362	—
53	MSFTMicrosoft	37,500	—
54	ANNXAnnexon	4,458,646	—
55	DMRADamora Bio	900,000	—
56	ZURAZura Bio	3,734,866	—
57	TYRATyra Biosciences	725,000	—
58	NOWServiceNow	100,000	—
59	RZLTRezolute	3,328,287	—
60	NBISNebius Group	52,000	—
61	ENGNenGene Holdings	6,256,662	—
62	IKTInhibikase Therapeutics	5,850,000	—
63	DDOGDatadog	40,000	—
64	GENBGenerate Biomedicines	736,104	—
65	DTDynatrace	155,000	—
66	FROGJFrog	95,500	—
67	AGENAgenus	1,064,250	—
68	AVGOBroadcom	25,000	—
69	CTMXCytomX Therapeutics	3,457,711	—
70	WHWKWhiteHawk Therapeutics	2,337,102	—
71	AMZNAmazon	32,500	—
72	ADAGAdagene	2,666,666	—
73	MSLESatellos Bioscience	892,074	—
74	IONQIonQ	170,000	—
75	IRENIREN	175,000	—
76	PDDPDD Holdings	95,000	—
77	DSGNDesign Therapeutics	523,212	—
78	GTLBGitLab	125,000	—
79	ELOXEloxx Pharmaceuticals, Inc.	400,000	—
80	SEERSeer	2,458,673	—
81	OCSOculis Holding	625,000	—
82	BABAAlibaba Group	50,000	—
83	VTVTvTv Therapeutics	163,000	—
84	MPLTMapLight Therapeutics	450,000	—
85	NMRANeumora Therapeutics	8,497,822	—
86	ODTXOdyssey Therapeutics	200,000	—
87	IVVDInvivyd	5,000,000	—
88	AGMBAgomab Therapeutics	411,250	—
89	CLBTCellebrite	311,544	—
90	KRROKorro Bio	347,718	—
91	MNDYmonday.com	42,500	—
92	WKWorkiva	45,000	—
93	SIONSionna Therapeutics	610,515	—
94	OUSTOuster	67,500	—
95	PALIPalisade Bio	2,000,000	—
96	NBPNovaBridge Biosciences	2,004,739	—
97	CRWDCrowdStrike	10,000	—
98	ZTSZoetis	35,000	—
99	AEVAAeva Technologies	145,459	—
100	ENTXEntera Bio	736,457	—
101	NFLXNetflix	25,000	—
102	BEKEKE Holdings	100,000	—
103	RANIRani Therapeutics Holdings	2,000,000	—
104	FHTXFoghorn Therapeutics	720,720	—
105	TSLATesla	3,500	—
106	KLRSKalaris Therapeutics	435,798	—
107	LITELumentum Holdings	1,055	—
108	FIGFigma	50,000	—
109	QNTQuantinuum Inc.	20,000	—
110	MDLNMedline	25,000	—
111	TENXTenax Therapeutics	427,141	—
112	FOXAFox Corporation (Class A)	10,000	—
113	TAT&T	25,000	—
114	NUNu Holdings	25,000	—
115	CRNXCRNX	1,420,788	—

2026年6月30日時点の SEC への Form 13F 届出 (運用資産 $100M 以上の機関投資家が四半期ごとに提出) の集計。届出は四半期末から最大45日遅れで公開されるため、現在の保有と異なる場合があります。概算評価額と構成比は当サイトの株価で計算した参考値です。届出対象外の資産 (米国外上場株・債券など) は含まれません。